Skip to main content

Table 4 Comparison between Ebstein anomaly patient groups with different ECV

From: Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein’s anomaly

 

ECV ≥ 30%(N = 20)

ECV < 30%(N = 24)

P

Age, yrs

34.9 ± 15.7

32.6 ± 16.7

0.648

Male (n, %)

6 (30.0)

12 (50.0)

0.227

Heart rate, bpm

83.6 ± 11.0

83.0 ± 14.0

0.852

BMI, kg/m2

21.2 ± 4.3

22.2 ± 5.2

0.488

NYHA classification

2.1 ± 0.4

1.7 ± 0.6

0.020

SO2 at rest, %

96.2 ± 2.6

97.0 ± 2.8

0.411

Severe tricuspid regurgitation (n, %)

18 (90.0)

14 (58.3)

0.019

ASD/PFO (n, %)

15 (75.0)

14 (58.3)

0.342

W-P-W (n, %)

3 (15.0)

3 (12.5)

0.329

Hematocrit, %

40.0 ± 4.3

44.7 ± 4.5

0.001

QRS width, ms

113.2 ± 17.3

114.1 ± 14.9

0.862

LV EDV index, ml/m2

67.7 [26.0]

70.3 [13.2]

0.671

LV ESV index, ml/m2

35.6 [18.7]

31.0 [7.1]

0.259

LV EF, %

48.0 ± 8.3

56.7 ± 4.7

< 0.001

fRV EDV index, ml/m2

168.1 [77.7]

121.4 [56.8]

0.026

fRV ESV index, ml/m2

100.0 [53.7]

63.6 [29.3]

0.011

fRV EF, %

38.4 ± 12.3

46.2 ± 11.0

0.117

aRV EDV index, ml/m2

89.0 ± 58.4

59.1 ± 39.7

0.051

Total R/L-Volume-Index

5.8 ± 2.8

3.1 ± 1.4

< 0.001

SI

1.13 ± 0.4

0.86 ± 0.4

0.036

  1. Abbreviations: ECV extracellular volume; BMI body mass index; NYHA New York Heart Association; ASD atrial septal defect; PFO patent foramen ovale; W-P-W Wolff-Parkinson-White; LV left ventricle; EDV end diastolic volume; ESV end systolic volume; EF ejection fraction; fRV functional right ventricle; aRV atrialized right ventricle; Total R/L-Volume-Index, total right/left volume index; SI severity index